For Air Products & Chemicals Inc (NYSE:APD), Vertical Research upgraded the previous rating of Hold to Buy. For the first quarter, Air Products & Chemicals had an EPS of $2.64, compared to year-ago quarter EPS of $2.52. At the moment, the stock has a 52-week-high of $328.56 and a 52-week-low of $216.41. Air Products & Chemicals closed at $281.27 at the end of the last trading period.

According to DA Davidson, the prior rating for PacWest Bancorp (NASDAQ:PACW) was changed from Neutral to Buy. In the fourth quarter, PacWest Banc showed an EPS of $0.55, compared to $1.14 from the year-ago quarter. The current stock performance of PacWest Banc shows a 52-week-high of $46.84 and a 52-week-low of $12.21. Moreover, at the end of the last trading period, the closing price was at $12.35.

According to Citigroup, the prior rating for PNC Financial Services Group Inc (NYSE:PNC) was changed from Neutral to Buy. For the fourth quarter, PNC Finl Servs Gr had an EPS of $3.49, compared to year-ago quarter EPS of $3.68. At the moment, the stock has a 52-week-high of $199.43 and a 52-week-low of $132.30. PNC Finl Servs Gr closed at $137.16 at the end of the last trading period.

For Prosperity Bancshares Inc (NYSE:PB), Janney Montgomery Scott upgraded the previous rating of Neutral to Buy. In the fourth quarter, Prosperity Bancshares showed an EPS of $1.51, compared to $1.38 from the year-ago quarter. The current stock performance of Prosperity Bancshares shows a 52-week-high of $78.76 and a 52-week-low of $63.49. Moreover, at the end of the last trading period, the closing price was at $64.11.

Seaport Global upgraded the previous rating for Wolverine World Wide Inc (NYSE:WWW) from Neutral to Buy. For the fourth quarter, Wolverine World Wide had an EPS of $0.15, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $24.95 and a 52-week-low of $9.60. Wolverine World Wide closed at $15.88 at the end of the last trading period.

According to RBC Capital, the prior rating for Sage Therapeutics Inc (NASDAQ:SAGE) was changed from Sector Perform to Outperform. In the fourth quarter, Sage Therapeutics showed an EPS of $2.47, compared to $2.12 from the year-ago quarter. The stock has a 52-week-high of $49.56 and a 52-week-low of $27.36. At the end of the last trading period, Sage Therapeutics closed at $39.56.

Wells Fargo upgraded the previous rating for Amgen Inc (NASDAQ:AMGN) from Equal-Weight to Overweight. In the fourth quarter, Amgen showed an EPS of $4.09, compared to $4.36 from the year-ago quarter. The current stock performance of Amgen shows a 52-week-high of $296.67 and a 52-week-low of $223.30. Moreover, at the end of the last trading period, the closing price was at $227.87.

According to Wells Fargo, the prior rating for JPMorgan Chase & Co (NYSE:JPM) was changed from Equal-Weight to Overweight. In the fourth quarter, JPMorgan Chase showed an EPS of $3.57, compared to $3.33 from the year-ago quarter. The current stock performance of JPMorgan Chase shows a 52-week-high of $144.34 and a 52-week-low of $101.28. Moreover, at the end of the last trading period, the closing price was at $133.65.

For Truist Financial Corp (NYSE:TFC), Keefe, Bruyette & Woods upgraded the previous rating of Underperform to Market Perform. For the fourth quarter, Truist Finl had an EPS of $1.30, compared to year-ago quarter EPS of $1.38. At the moment, the stock has a 52-week-high of $61.10 and a 52-week-low of $37.85. Truist Finl closed at $38.84 at the end of the last trading period.

For Seagen Inc (NASDAQ:SGEN), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. In the fourth quarter, Seagen showed an EPS of $0.80, compared to $0.95 from the year-ago quarter. The current stock performance of Seagen shows a 52-week-high of $183.00 and a 52-week-low of $105.43. Moreover, at the end of the last trading period, the closing price was at $172.61.

According to Odeon Capital, the prior rating for Comerica Inc (NYSE:CMA) was changed from Buy to Hold. Comerica earned $2.58 in the fourth quarter, compared to $1.66 in the year-ago quarter. The current stock performance of Comerica shows a 52-week-high of $97.52 and a 52-week-low of $56.91. Moreover, at the end of the last trading period, the closing price was at $58.81.

Argus Research downgraded the previous rating for Advance Auto Parts Inc (NYSE:AAP) from Buy to Hold. Advance Auto Parts earned $2.88 in the fourth quarter, compared to $2.07 in the year-ago quarter. The current stock performance of Advance Auto Parts shows a 52-week-high of $231.43 and a 52-week-low of $127.48. Moreover, at the end of the last trading period, the closing price was at $128.04.

For Diversey Holdings Ltd (NASDAQ:DSEY), Credit Suisse downgraded the previous rating of Outperform to Neutral. Diversey Hldgs earned $0.09 in the third quarter, compared to $0.10 in the year-ago quarter. The current stock performance of Diversey Hldgs shows a 52-week-high of $10.68 and a 52-week-low of $3.95. Moreover, at the end of the last trading period, the closing price was at $8.11.

Citigroup downgraded the previous rating for Petco Health and Wellness Co Inc (NASDAQ:WOOF) from Buy to Neutral. In the third quarter, Petco Health and Wellness showed an EPS of $0.16, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $22.75 and a 52-week-low of $8.72. At the end of the last trading period, Petco Health and Wellness closed at $10.05.

Odeon Capital downgraded the previous rating for Wells Fargo & Co (NYSE:WFC) from Buy to Hold. For the fourth quarter, Wells Fargo had an EPS of $0.67, compared to year-ago quarter EPS of $1.38. The current stock performance of Wells Fargo shows a 52-week-high of $54.20 and a 52-week-low of $36.54. Moreover, at the end of the last trading period, the closing price was at $41.36.

Bernstein downgraded the previous rating for Lam Research Corp (NASDAQ:LRCX) from Outperform to Market Perform. Lam Research earned $10.71 in the second quarter, compared to $8.53 in the year-ago quarter. The current stock performance of Lam Research shows a 52-week-high of $574.79 and a 52-week-low of $299.59. Moreover, at the end of the last trading period, the closing price was at $478.82.

Wells Fargo downgraded the previous rating for Merck & Co Inc (NYSE:MRK) from Overweight to Equal-Weight. In the fourth quarter, Merck & Co showed an EPS of $1.62, compared to $1.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $115.49 and a 52-week-low of $77.31. Merck & Co closed at $107.69 at the end of the last trading period.

For First Republic Bank (NYSE:FRC), Raymond James downgraded the previous rating of Strong Buy to Market Perform. In the fourth quarter, First Republic Bank showed an EPS of $1.88, compared to $2.02 from the year-ago quarter. The current stock performance of First Republic Bank shows a 52-week-high of $174.21 and a 52-week-low of $45.00. Moreover, at the end of the last trading period, the closing price was at $81.76.

According to Keefe, Bruyette & Woods, the prior rating for Trinity Capital Inc (NASDAQ:TRIN) was changed from Market Perform to Underperform. For the fourth quarter, Trinity Cap had an EPS of $0.57, compared to year-ago quarter EPS of $0.38. At the moment, the stock has a 52-week-high of $20.26 and a 52-week-low of $10.23. Trinity Cap closed at $12.40 at the end of the last trading period.

According to Keefe, Bruyette & Woods, the prior rating for Hercules Capital Inc (NYSE:HTGC) was changed from Market Perform to Underperform. Hercules Capital earned $0.47 in the fourth quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.09 and a 52-week-low of $11.16. Hercules Capital closed at $12.29 at the end of the last trading period.

For First Republic Bank (NYSE:FRC), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the fourth quarter, First Republic Bank had an EPS of $1.88, compared to year-ago quarter EPS of $2.02. The stock has a 52-week-high of $174.21 and a 52-week-low of $45.00. At the end of the last trading period, First Republic Bank closed at $81.76.

With a Buy rating, Craig-Hallum initiated coverage on Phathom Pharmaceuticals Inc (NASDAQ:PHAT). The price target seems to have been set at $21.00 for Phathom Pharmaceuticals. For the fourth quarter, Phathom Pharmaceuticals had an EPS of $1.33, compared to year-ago quarter EPS of $0.95. At the moment, the stock has a 52-week-high of $16.07 and a 52-week-low of $6.09. Phathom Pharmaceuticals closed at $7.27 at the end of the last trading period.

Credit Suisse initiated coverage on Cabot Corp (NYSE:CBT) with an Outperform rating. The price target for Cabot is set to $94.00. Cabot earned $0.98 in the first quarter, compared to $1.29 in the year-ago quarter. The current stock performance of Cabot shows a 52-week-high of $83.73 and a 52-week-low of $59.65. Moreover, at the end of the last trading period, the closing price was at $74.31.

Credit Suisse initiated coverage on Orion Engineered Carbons SA (NYSE:OEC) with an Outperform rating. The price target for Orion Engineered Carbons is set to $31.00. In the fourth quarter, Orion Engineered Carbons showed an EPS of $0.26, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.91 and a 52-week-low of $12.87. Orion Engineered Carbons closed at $24.53 at the end of the last trading period.

With an Outperform rating, Evercore ISI Group initiated coverage on GE HealthCare Technologies Inc (NASDAQ:GEHC). The price target seems to have been set at $90.00 for GE HealthCare Techs. For the fourth quarter, GE HealthCare Techs had an EPS of $1.31, compared to year-ago quarter EPS of $1.36. The stock has a 52-week-high of $77.40 and a 52-week-low of $53.50. At the end of the last trading period, GE HealthCare Techs closed at $74.97.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Nikola Corp (NASDAQ:NKLA). The price target seems to have been set at $3.00 for Nikola. Nikola earned $0.37 in the fourth quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.87 and a 52-week-low of $1.64. Nikola closed at $1.66 at the end of the last trading period.

With a Equal-Weight rating, Barclays initiated coverage on Amedisys Inc (NASDAQ:AMED). The price target seems to have been set at $93.00 for Amedisys. In the fourth quarter, Amedisys showed an EPS of $1.16, compared to $1.18 from the year-ago quarter. The stock has a 52-week-high of $179.91 and a 52-week-low of $79.30. At the end of the last trading period, Amedisys closed at $82.56.